
231. Can The NHS Afford The UK-US Pharma Deal?
The Rest Is Money
00:00
UK strengths: sectors to back and grow
Patrick highlights UK advantages in life sciences, AI, quantum and materials science for targeted investment.
Play episode from 14:36
Transcript


